Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis
- PMID: 12451624
- DOI: 10.1002/jso.10178
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis
Abstract
Background and objectives: The objective of this investigation was to study the clinicopathological factors influencing long-term outcome of hepatocellular carcinoma (HCC) with liver cirrhosis in patients undergoing hepatectomy. Liver cirrhosis, especially the macronodular variety, has been found in up to 90% of patients with HCC. In Asia, the incidence of liver cirrhosis in patients with HCC who had undergone hepatic resection varies from 42.5% to 73.8%. However, the optimal surgical approach for HCC patients with cirrhosis is less clearly defined. Resection of the cirrhotic liver is challenging and remains controversial in the treatment of HCC.
Methods: This study retrospectively analyzed the surgical outcomes of HCC concomitant with liver cirrhosis in 218 patients who underwent hepatic resection between 1986 and 1998. Post-resection prognostic factors were assessed using a univariate log-rank test and a multivariate Cox proportional hazards model.
Results: The overall postoperative complication rate was 15.6%, while the surgical mortality rate was 8.8%. Meanwhile, the 1-, 3-, and 5-year disease-free survival rates were 50.9%, 33.98%, and 27.03%, respectively, and. the overall cumulative survival rates at 1, 3, and 5 years were 63.14%, 41.88%, and 31.83%, respectively. Applying Cox's multivariate proportional hazard model indicated that significant adverse prognostic indicators included elevated alkaline phosphatase value, tumor size >2 cm, presence of satellite lesions, and vascular invasion.
Conclusions: This investigation found that overall survival for HCC patients concomitant with liver cirrhosis who underwent hepatic resection should be stratified on the basis of the high value of alkaline phosphatase, tumor size, satellite lesions, and vascular invasion.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23. Hepatogastroenterology. 2002. PMID: 11995486
-
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017. J Am Coll Surg. 2004. PMID: 14992736
-
Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.Am J Gastroenterol. 2001 Apr;96(4):1243-50. doi: 10.1111/j.1572-0241.2001.03634.x. Am J Gastroenterol. 2001. PMID: 11316177
-
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].Zentralbl Chir. 2009 Apr;134(2):127-35. doi: 10.1055/s-0028-1098881. Epub 2009 Apr 20. Zentralbl Chir. 2009. PMID: 19382043 Review. German.
-
Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.Int J Oncol. 2002 Aug;21(2):427-32. Int J Oncol. 2002. PMID: 12118341 Review.
Cited by
-
Effects of implementing an "enhanced recovery after surgery" program on patients undergoing resection of hepatocellular carcinoma.Surg Today. 2017 Jan;47(1):42-51. doi: 10.1007/s00595-016-1344-2. Epub 2016 May 10. Surg Today. 2017. PMID: 27165267
-
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.Onco Targets Ther. 2015 Jul 28;8:1899-907. doi: 10.2147/OTT.S78728. eCollection 2015. Onco Targets Ther. 2015. PMID: 26251613 Free PMC article.
-
Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.Int J Clin Exp Med. 2010 Jun 10;3(2):169-79. Int J Clin Exp Med. 2010. PMID: 20607043 Free PMC article.
-
A new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomy.Cancer Biol Med. 2018 Nov;15(4):415-424. doi: 10.20892/j.issn.2095-3941.2018.0095. Cancer Biol Med. 2018. PMID: 30766751 Free PMC article.
-
Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma.Oncotarget. 2017 Jul 11;8(28):45837-45847. doi: 10.18632/oncotarget.17434. Oncotarget. 2017. PMID: 28507277 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical